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Abstract
Mouse models of human diseases are used to study the metabolic and physio-
logical processes leading to altered whole-body energy expenditure (EE),
which is the sum of EE of all body organs and tissues. Isotopic techniques,
arterio-venous difference of substrates, oxygen, and blood flow measurements
can provide essential information to quantify tissue/organ EE and substrate
oxidation. To complement and integrate experimental data, quantitative math-
ematical model analyses have been applied in the design of experiments and
evaluation of metabolic fluxes. In this study, a method is presented to quan-
tify the energy expenditure of the main mouse organs using metabolic flux
measurements. The metabolic fluxes and substrate utilization of the main
metabolic pathways of energy metabolism in the mouse tissue/organ systems
and the whole body are quantified using a mathematical model based on mass
and energy balances. The model is composed of six organ/tissue compart-
ments: brain, heart, liver, gastrointestinal tract, muscle, and adipose tissue.
Each tissue/organ is described with a distinct system of metabolic reactions.
This model quantifies metabolic and energetic characteristics of mice under
overnight fasting conditions. The steady-state mass balances of metabolites
and energy balances of carbohydrate and fat are integrated with available
experimental data to calculate metabolic fluxes, substrate utilization, and oxy-
gen consumption in each tissue/organ. The model serves as a paradigm for
designing experiments with the minimal reliable measurements necessary to
quantify tissue/organs fluxes and to quantify the contributions of tissue/organ
EE to whole-body EE that cannot be easily determined currently.
Introduction
Mouse-human metabolism relation
Mouse models are valuable tools to investigate and iden-
tify metabolic processes that regulate energy metabolism
and body weight (BW) (Tam et al. 2009; Guo and Hall
2011). The results obtained from the models in mice can
be translated to humans to a large extent because mice
and humans share similar physiological functions at cellu-
lar, tissue/organ, and whole-body levels (Rangarajan and
Weinberg 2003; Shultz et al. 2007). However, subtle yet
important distinctions are evident in the energy metabo-
lism of mice and humans. For example, the energy expen-
diture (EE) per gram of body weight in mice is seven
times higher than that in humans (Blaxter 1989; Wang
et al. 2012) and EE per unit mass of liver and brain is
respectively eight times and three times higher in mice
than that in humans (Wang et al. 2012). Even though
mice and humans share metabolic similarities associated
with energy metabolism, the magnitude of these processes
in organs and tissues differ significantly between them.
Thus, it is important to identify and quantify the meta-
bolic processes that lead to those distinctions in mice and
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humans for translational research of metabolic diseases.
Because key metabolic data are limited and difficult to
obtain, modeling is necessary to identify and quantify
the metabolic processes involving mice models of human
disease.
Significance of altered metabolic fluxes
Fuel homeostasis in the whole body requires coordination
of metabolic fluxes among organs and tissues. These are
regulated by neuroendocrine and hormonal factors (Hall
2006; Kim et al. 2007; Pattaranit and van den Berg 2008).
The whole-body metabolic fluxes that are important for
energy metabolism are glycolysis, glycogenolysis, gluco-
neogenesis, lipolysis, de novo lipogenesis, triglyceride-fatty
acid cycling, proteolysis, and oxidation of macronutrients
(carbohydrate, fat, and protein). The total EE is equal to
sum of the rates of oxidation of macronutrients. These
fluxes change in chronic disease (e.g., diabetes), exercise
and dietary perturbations as a result of altered cellular
metabolic processes in various tissues and organs (Hall
2006; Kim et al. 2007; Pattaranit and van den Berg 2008).
These pathophysiologic perturbations alter metabolic
pathways and fluxes in individual organs and alter inter-
organ exchange rates of substrates with subsequent
changes in substrate utilization, EE, and BW (Hall 2006;
Kim et al. 2007; Pattaranit and van den Berg 2008).
Although most metabolic pathways of substrate utilization
are known, the relationships between these pathways and
body weight regulation are yet to be quantified. By quan-
tifying EE and metabolic pathway fluxes in organs and
tissues, we can obtain key information that relates
changes in metabolic processes with regulation of energy
metabolism and BW in disease.
EE and metabolic fluxes
Several techniques are available to measure organ/tissue
EE and metabolic fluxes in animal models and humans.
The product of blood flow and arterio-venous difference
of oxygen is commonly used to determine organ/tissue
oxygen consumption (VO2) in vivo. The VO2 of different
organs/tissues is then used to quantify their contribution
to the whole-body EE (Elia 1992). The application of this
approach is limited in mice because it is challenging to
measure blood flow and arterio-venous difference of oxy-
gen across organs/tissues. Alternatively, investigators have
used allometric equations of EE and BW to obtain organ
EE in animals (Wang et al. 2012). This approach does
not account for changes in body composition and its
contribution to whole-body energy metabolism. Stable
isotope tracers combined with measurements of isoto-
pomer labeling using NMR and mass spectroscopy are
used to determine metabolic pathway fluxes in vivo (Choi
and Antoniewicz 2011). However, they require fairly large
amount of sample, long analytical time, and expensive
equipment and provide partial information about the dis-
tribution of isotopomers. Thus, it is desirable to identify
the minimal number of the metabolic flux measurements
required to quantify the energy metabolism of each organ
in relation to the whole-body energy expenditure.
Mathematical models of energy metabolism
To relate energy metabolism to the regulation of BW in
humans and mice, mathematical models have been devel-
oped (Hall 2006, 2012; Tam et al. 2009; Guo and Hall
2011). Although these models can identify whole-body
metabolic fluxes responsible for changes in body weight
and composition in response to dietary changes, they do
not quantify the metabolic processes in the organs
responsible for body weight regulation. Previously, a com-
plementary approach was developed to evaluate metabolic
fluxes of organs and tissues by integrating stoichiometric
metabolic network models with organ/tissue measure-
ments of uptake and/or production of metabolites and
metabolic fluxes (Kim et al. 2007, 2011; Li et al. 2009).
By this method, in vivo fluxes can be quantified and
relate metabolism of organs and tissues to whole-body at
rest and during exercise in humans. In this study a simi-
lar mathematical approach is applied to quantify organ/
tissue metabolic fluxes in mice.
Here, we develop a unique quantitative framework to
estimate metabolic fluxes of the main pathways of energy
metabolism in key tissue/organs of the mouse. Our math-
ematical framework integrates mass balances, energy bal-
ances, and metabolic fluxes obtained from the literature.
Specific assumptions are also used to estimate metabolic
fluxes that are difficult to measure in each organ of the
mouse and are not available in literature. Consequently,
the model is used to evaluate (1) the metabolic pathway
fluxes of tissues and organs from a limited set of experi-
mental data and (2) the contribution of tissue/organ
energy metabolism to whole-body energy metabolism.
Furthermore, by quantifying differences of whole-body
and intraorgan metabolic fluxes between mouse and
human, we could relate energy metabolism of mice to
humans.
Methods
Overview
In this work, a model paradigm is developed to relate
organ-level energy expenditure to metabolic flux as an
alternative to the Fick principle in mice. The main goal is
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to provide a method to quantify the energy expenditure
of organs using metabolic fluxes of the main pathways
involved in fuel metabolism. Here, the main organs and
tissues involved in lipid, carbohydrates, and protein
metabolism and the organs for which there is sufficient
metabolic information about mice are considered. The
methodology presented here allows quantitative analysis
of metabolic fluxes (MF) of overnight-fasted mouse
organs/tissues: brain, heart, liver, skeletal muscle, adipose
tissue, and gastrointestinal tract (GI), which includes
stomach, spleen, intestines, and visceral fat. The model
provides a mechanistic framework to study substrate utili-
zation in each organ. Liver, gastrointestinal (GI) tract,
skeletal muscle, and adipose tissue are key organs/tissues
that contribute to the adaptive responses to pathophysio-
logical conditions and provide metabolic fuels necessary
for sustenance. Additionally, brain and heart consume
energy for sending biochemical signals and transport
energy. Because of insufficient data on fuel metabolism of
lung and kidney in mice, these organs are not included.
Steady-state mass balance equations are developed for
each key metabolite in the biochemical pathways of
organs and tissues. This builds upon the approach by oth-
ers (Kim et al. 2007) used to determine organ/tissue MFs
of humans. For mice, however, data are lacking in regard
to rates of substrate uptake/release and MFs to construct
all the pathway fluxes of organs/tissues. To compensate
for this lack of data, the mathematical model combines
mass and energy balances to quantify organ/tissue energy
expenditure (EE). Consequently, this model analysis yields
MFs, substrate uptake/release, substrate utilization, oxygen
consumption (VO2), and carbon dioxide production
(VCO2) in various organs/tissues of mice. The data inputs
given in Tables 1–4 and 10 allow the mathematical model
(Fig. 1) to predict the data outputs (Table 5–9 and 12).
Mathematical model
Based on the primary function of the organ/tissue in the
whole-body energy metabolism, we specified the major
specialized metabolic pathways, which dictate the
exchange and distribution of metabolic fuels among tis-
sues/organs. The main metabolic fuels that exchange
among tissues and organs via blood circulation are glu-
cose, free fatty acid, glycerol, triglyceride, lactate, and
amino acids (represented here by alanine) (Fig. 2). The
systems of metabolic reactions that are present in each
tissue and organ are provided in Figure 2 and
Appendix 1 (Kim et al. 2007). The distinctive metabolic
reactions present in each tissue and organ are shown in
Figure 3. The protein breakdown is present in most
of the organs/tissues after overnight fasting, however,
we considered proteolysis only in skeletal muscle because
in all other organs the contribution of proteolysis to
whole body is not significant compared to skeletal
muscle. Furthermore, although gluconeogenesis also
takes place in the GI tract but we neglected for this
analysis because its contribution to the whole body is
not significant.
Mass balances
A system of mass balance equations is defined for each
tissue/organ system. The mass balance for each metabolite
is based on the metabolic flux (production/utilization)
and uptake/release rates of the metabolite in each tissue/
organ. The metabolic fluxes of substrate production and
utilization in tissues and organs depend on many com-
plex biochemical reactions. We assume that the tissue and
Table 1. Metabolic fluxes (MFs) of mouse organs/tissues.
Organ/tissue MF (lmol/min/kg)1 Reference
Brain /GLY?G6P 2.0 (Kim et al. 2007)
/PYR?LAC 469.8 (Kim et al. 2007)
Heart /GLY?G6P 160.0 (Kim et al. 2007)
/PYR?LAC 352.0 (Kim et al. 2007)
/TG?GLR 16.0 (Kim et al. 2007)
Liver /GLC?G6P 73.1
2 (Mulligan and
Tisdale 1991)
/G6P?GAP 73.1
3 (Kim et al. 2007)
/GAP?PYR 146.2
3 (Kim et al. 2007)
/PYR?LAC 140.0 (Kim et al. 2007)
/G6P?GLY 66.0 (Kim et al. 2007)
/GLY?G6P 305.4
2 (Chacko et al. 2012)
/TG?GLR 2.7 (Kim et al. 2007)
/AcoA?FFA 74.7 (Kim et al. 2007)
/PYR?ACoA 0.0 (Kim et al. 2007)
GI /PYR?LAC 100.0 (Kim et al. 2007)
Skeletal
muscle
/LAC?PYR 44.4 (Kim et al. 2007)
/GLY?G6P 6.2 (Kim et al. 2007)
/TG?GLR 6.5 (Kim et al. 2007)
Adipose tissue /PYR?LAC 3.3 (Kim et al. 2007)
/LAC?PYR 0.9 (Kim et al. 2007)
/FFA?TG 138.4
4 (Kim et al. 2007)
All fluxes otherwise indicated by 2, 3 and 4 are calculated using
the assumption that the metabolic fluxes (MFs) (per unit organ/tis-
sue mass) in mouse and human are similar.
The /GLC?G6P and /GLY?G6P in the mouse liver were obtained
using isotope tracers.
1per kg of organ weight.
2Experimental data.
3The relationships of MFs for /G6P?GAP (=/GLC?G6P) and /GAP?
PYR (=2x/GLC?G6P) in mouse liver were based on the fluxes in
human liver.
4The relationship of MFs for /FFA?TG (=0.2/TG?FFA) in mouse adi-
pose tissue was based on the fluxes in human adipose tissue.
20% of the FFA resulted from lipolysis reesterified to TG.
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capillary subcompartments are spatially lumped in all tis-
sues and organs. The concentration dynamics Cx,i(t) of
each substrate (i) in each tissue and organ (x) can be
described by the following dynamic mass balance
equation:
Vx;i
dCx;i
dt
¼ Px;i  Ux;i þQxðCa;i  Cxv;iÞ (1)
where Vx,i is the volume of substrate i in tissue or organ
x, Px,i, and Ux,i are the substrate production and utiliza-
Table 2. Mouse organ/tissue substrate uptake/release rates.
Organ/tissue
Uptake (Upt)
Release (Rel)
Uptake/Release as
%Ra of substrate Upt/Rel (lmol/min/kg)
1 Reference
Heart UptLAC 12.9% of Ra,LAC 708.3 (Kim et al. 2007)
Liver RelGLC 100% Ra,GLC 1154.8
2 (Chacko et al. 2012)
RelTG 100% Ra,TG 10.8 (Kim et al. 2007)
UptGLR 100% of Ra,GLR 545.7 (Kim et al. 2007)
UptALA 100% of Ra,ALA 860.2 (Kim et al. 2007)
GI UptTG 20.7% of Ra,TG 1.6 (Kim et al. 2007)
RelFFA 36.2% of Ra,FFA 353.3 (Kim et al. 2007)
Skeletal muscle UptGLC Mouse data 58.3
2 (Toyoda et al. 2011)
RelLAC 36.1% of Ra,LAC 32.8 (Kim et al. 2007)
UptTG 10.3% of Ra,TG 0.2 (Kim et al. 2007)
RelGLR – 0.2
3 (Kim et al. 2007)
RelALA 100% of Ra,ALA 155.8 (Kim et al. 2007)
Adipose tissue UptTG 69% of Ra,TG 4.5 (Kim et al. 2007)
RelGLR 70.4% of Ra,GLR 230.6 (Kim et al. 2007)
RelFFA 63.7% of Ra,FFA 531.2 (Kim et al. 2007)
Ra, appearance rate; Upt, substrate uptake; Rel, substrate release rate.
All substrate uptake/release rates otherwise indicated by 2 and 3 are calculated using the following assumption. The appearance rate fraction
of metabolic fuels taken out (or released) of (or into) plasma by organs/tissues is similar in both human and mouse. Mouse organ/tissue sub-
strate uptake/release rates were calculated by multiplying appearance rate fraction of metabolic fuels of human organs/tissues with mouse
appearance rate of substrates in plasma (Ra,i) reported in Table 10.
The RelGLC from liver and UptGLC into skeletal muscle were determined using isotope tracers.
1Per kg of organ weight.
2Experimental data.
3The relationships of RelGLR = UptTG in mouse muscle was based on the substrate uptake/release rate in human muscle.
Table 3. Mouse and human physiological parameters.
Organ/Tissue
Mass Blood flow
Respiratory quotient
(RQ) (Kim et al. 2007)3
Mouse (Martin and
Fuhrman 1955)
Human (Lindstedt
and Schaeffer 2002;
Kim et al. 2007)
Mouse (Fenneteau
et al. 2009) Human (Kim et al. 2007) Mouse/Human
(g) (% of BW) (103g) (% of BW) (mL/min/100 g)1 (mL/min/100 g)1 ()
Brain 0.54 1.8 1.49 2.1 98.15 50.34 1.0
Heart 0.17 0.57 0.25 0.36 658.82 100.0 0.79
Liver 1.86 6.2 1.5 2.1 146.77 100.0 0.72
GI tract 2.65 8.83 2.0 2.9 90.19 55.0 1.0
Skeletal Muscle 10.27 34.23 27.8 39.7 26.19 3.24 0.78
Adipose Tissue 3.10 10.33 11.0 15.7 38.39 3.27 0.81
Others 11.41 38.03 25.96 37.1 55.21 2.47 0.80/0.67 (this work)
Whole body 30.0 100.0 70.0 100.0 56.47 7.86 0.77/0.82
We assumed that mouse and human organs have same RQ.
1Per 100g of organ weight.
2Mouse whole-body RQ is 0.77 (Kaiyala et al. 2010) and human whole-body RQ is 0.8 (Kim et al. 2007).
3Mouse and or human.
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tion rates in tissue or organ x. Qx is the tissue or organ
blood flow rate. The input arterial concentration is Ca,i
and the output venous concentration is Cxv,i. At steady
state, the transient term is zero so that
0 ¼ Px;i  Ux;i þ QxðCa;i  Cxv;iÞ (2)
The uptake (Uptx,i) or release (Relx,i) of substrate i in
tissue or organ x is related to blood flow and arterio-
venous difference:
Upt=Relx;i ¼ QxðCa;i  Cxv;iÞ (3)
For substrates that exist only within tissues/organs, we
set Qx = 0. The net rate of metabolic reaction is
Rx;i ¼ Px;i  Ux;i ¼
X
k
bk!i/x;k!i 
X
k
bi!k/x;i!k (4)
where /x,k?i and bk?i are the flux and stoichiometric
coefficient of the reaction from substrate k to substrate i,
respectively. The steady-state mass balance equations for
the system of reactions shown in Figure 2 and Appen-
dix 1 are presented in Appendix 2. The specific metabolic
functions of each tissue/organ system and the number of
metabolites in the pathways determine steady-state mass
balance equations of organs/tissues, which vary from one
organ/tissue to another.
Energy balances
The EE for each organ and tissue is related to the carbohy-
drate and fat oxidation according to the following equa-
tion:
/CHOATP!ADP;xCE
CHO þ /FATATP!ADP;xCEFAT  EEx ¼ 0 (5)
where CECHO and CEFAT are the calorific ATP equivalents
of carbohydrate and fat oxidation, respectively and
/CHOATP!ADP;x and /
FAT
ATP!ADP;x are the carbohydrate and fat
oxidation for organ x (Appendix 3). These fluxes are cal-
culated according to
/CHOATP!ADP;x ¼
X
j
bj!i/j!i;x;
/FATATP!ADP;x ¼
X
w
bw!i/w!i;x
(6)
• RQ
• Energy expenditure
• Substrate uptake/release rates 
• Metabolic fluxes 
Input
• Mass balance
• Energy balance
• Metabolic Pathways
Model
Output
• Metabolic fluxes
• Substrate uptake/release rates
• VO2 and VCO2 rates
• CHO and FAT rates
Organ/Tissue 
BRAIN
HEART
SKELETAL
MUSCLE
ADIPOSE
TISSUE
OTHERS
LIVER
GI TRACT
GAS EXCHANGE
O2 CO2
Whole Body A B
Figure 1. (A) Essential model inputs and equations for estimating computational outputs; (B) Whole-body systems:Venous (gray arrows) and
arterial blood (black arrows) leaving/going to the organ/tissue systems, respectively. RQ is respiratory quotient; VO2 and VCO2 are oxygen
consumption and carbon dioxide release rates respectively; CHO and FAT are rates of carbohydrate and fat utilization.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 9 | e12159
Page 5
C. M. Kummitha et al. Comparison of Mouse and Human Energy Metabolism
where /j!i;x, /w!i;x and bj?i, bw?i are fluxes and stoichi-
ometric coefficients of the reaction from substrate j (or
w) to substrate i associated with carbohydrate (or fat) uti-
lization.
We solved coupled steady-state mass and energy bal-
ance equations numerically to obtain estimates of mouse
organ/tissue MFs (using MATLAB R2011b, fsolve). We
also computed rates of substrate utilization, VO2, and
VCO2 for each organ/tissue from the MFs. A model cal-
culation for estimating liver metabolic fluxes is provided
in the Appendix 6. The “others” organs/tissues VO2 is
determined by subtracting the VO2 of brain, heart, liver,
GI tract, muscle, and adipose tissue from the whole-body
VO2.
We also used standard empirical relationships (Tang
et al. 2002) to compute whole-body and organ/tissue
(x = brain, liver, heart, skeletal muscle, adipose tissue, GI
tract, others) VO2:
VO2;x¼EEx=ð3:78þ1:24RQxÞ; RQx¼VCO2;x=VO2;x (7)
The VO2 and VCO2 rates (per unit mass of organ/tis-
sue) thus obtained using both FBA and standard
approach are compared.
Table 4. EE of mouse and human organs/tissues.
Organ/Tissue
Mouse Human
Mouse/Human
(kcal/kg/day)1 (kcal/day) (%) (kcal/kg/day)1 (kcal/day) (%) Xi-fold
Brain 740.7 0.4 6.42 247.1 368.2 21.35 3.0
Heart 1352.9 0.23 3.69 705.5 176.4 10.23 1.92
Liver 1747.3 3.25 52.17 224.5 336.7 19.53 7.78
GI tract 52.8 0.14 2.25 36.8 73.6 4.27 1.43
Skeletal muscle 78.9 0.81 13.0 13.0 361.9 20.99 6.06
Adipose tissue 100.0 0.31 4.98 4.1 44.9 2.6 24.5
Others 95.6 1.09 17.5 14 362.7 21.03 6.84
Whole body 207.7 6.23 100.0 24.6 1724.4 100.0 8.43
EE of brain, heart, liver were determined using allometric equations that relate organ/tissue EE to body mass. The EE of GI tract and “others”
were obtained using “residual organs” allometric equation (Wang et al. 2012). “Others” includes the rest of the organs/tissues including kid-
neys. Adipose tissue EE was determined from FM EE (Guo and Hall 2011). Muscle EE was determined by subtracting brain, heart, liver, GI
tract, and others EE from FFM EE (Guo and Hall 2011; Wang et al. 2012).
Human organ/tissue EE was determined from sum of carbohydrate and fat utilization rates (Kim et al. 2007).
Xi-fold for each organ/tissue: mouse EE (kcal/kg/day)/human EE (kcal/kg/day).
1Per kg of organ weight.
Table 5. Mouse and human organ/tissue substrate uptake/release rates.
Organ/Tissue Substrate
Substrate Uptake/Release (lmol/min/kg)1
Mouse Human
Calculated Measured Calculated/Measured
Brain Glucose 764.4 1270.0, 700.0 (Growdon et al. 1971;
Mulligan and Tisdale 1991)
255.0
Heart Glucose 108.7 49.1 (Matsui et al. 2006) 160.0
Free fatty acid 268.8 NA 140.0
Liver Free fatty acid 592.8 NA 140.0
Lactate 437.1 NA 180.0
GI tract Glucose 54.5 236 (Mulligan and Tisdale 1991) 38.0
Glycerol 117.82 NA 20.02
Skeletal muscle Free fatty acid 13.6 NA 2.3
Adipose tissue Glucose 59.1 43 (Mulligan and Tisdale 1991) 3.50
Lactate 2.42 NA 5.1
NA, not available.
1Per kg of organ weight.
2The negative sign indicates substrate release.
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Model inputs
Substrate uptake/release, metabolic fluxes, energy expendi-
ture, and respiratory quotients are the data inputs to the
organ/tissue mathematical model (Fig. 1). To the extent
possible, available data from literature are used. In the
absence of experimental data, specific assumptions are
made to determine metabolic pathway fluxes based on
current knowledge of fuel homeostasis in human and
mice. Quantification of the key information in each
organ/tissue of the mouse is described in the following
sections.
Mouse physiological parameters
The model analysis is based on a 30 g adult wild-type
mouse. The weights of the organs and tissues were deter-
mined from measurements of organ weights expressed as
percent of total body weight (Martin and Fuhrman 1955).
The rates of organ and tissue blood flow were calculated
from blood flow rates expressed as a fraction of the car-
diac output (Q) (Fenneteau et al. 2009). The mouse
organ and tissue weights and blood flows are reported in
Table 3. The respiratory quotient (RQ) of each organ and
tissue in mouse is assumed to be the same as that of an
overnight fasting human (Kim et al. 2007) (Table 3). This
assumption is consistent with the experimental evidence
that whole-body RQ under fasting conditions is similar in
both human and mice (Kim et al. 2007; Kaiyala et al.
2010).
Appearance rates of substrate in plasma
The appearance (or disappearance) of metabolic fuels in
plasma occurs when one or more organs and tissues
release (or take up) substrates. Under steady-state condi-
tions, the appearance rate equals the disappearance rate.
The rate of appearance of various substrates in plasma
measured in an overnight fasting (8–16 h) mouse from
tracer infusion studies are reported in Table 10 (Andriko-
poulos and Proietto 1995; Xu et al. 2002; Goudriaan et al.
2005; Bergman et al. 2006; Chacko et al. 2012).
Substrate uptake/release rates
The rate of uptake of glucose determined using isotope
tracers are available in literature for brain, heart, GI tract,
skeletal muscle, and adipose tissue (Tables 2 and 5).
Unknown mouse substrate uptake/release rates were cal-
culated based on appearance rates of substrate in the
plasma of mice and the fractional rates of substrate
uptake/release in humans (Table 2):
Upt=Relð Þi;x
h i
Mouse
¼ Upt=Relð Þi;x
Ra;i
 
Human
Ra;i
 
Mouse
(8)
Fractional rates of substrate uptake/release determine
tissue/organs contributions to appearance rates of sub-
strate in the plasma. It is assumed that the appearance
rate fractions of metabolic fuels taken (or released) out of
(or into) plasma by organs/tissues are similar in both
human and mouse (Table 2). Based on the literature
(Kim et al. 2007), we can specify substrate uptake (or
release) by (or from) each tissue and organ. We assume
that all the glucose that appears in plasma comes from
liver and all other organs/tissues consume glucose, which
holds true both in human and mouse. Adipose tissue
(AT) and GI tract are the sources of FFA in the plasma,
while all other organs consume FFA. Glycerol is released
from AT, GI tract, and skeletal muscle (SM), while liver
consumes all plasma glycerol. Triglyceride (TG) is
released by liver, while TG is consumed by the GI tract,
SM, and AT. Alanine is released by SM and consumed by
liver. We assumed alanine as the representative amino
acid of all amino acids. Lactate is released by SM, AT,
and “others” tissues (e.g., red blood cells) and consumed
by liver and heart. The organ/tissue substrate uptake/
release rates are presented in Tables 2.
Table 6. Mouse VO2 and VCO2 rates calculated with flux balance
analysis (FBA) and standard approach.
Organ/Tissue
VO2 (mL/min/kg
1) VCO2 (mL/min/kg
1)
FBA
Standard
approach FBA
Standard
approach
Brain 102.74 102.47 102.74 102.47
Heart 200.70 197.40 158.55 155.95
Liver 278.19 259.68 200.29 186.97
GI tract 7.33 7.31 7.33 7.31
Skeletal muscle 11.45 11.54 8.93 9.00
Adipose tissue 15.69 14.51 12.71 11.76
1Per kg of organ weight.
Table 7. Whole-body fuel metabolic fluxes.
Metabolic flux
Mouse Human Xi-fold
(lmol/min/kg)1 Mouse/Human
Glycogenolysis 14.8 5.4 2.7
Gluconeogenesis 56.8 5.0 11.4
De novo lipogenesis 4.8 0.3 16.7
Proteolysis 44.3 4.0 11.1
Lipolysis 36.7 3.9 9.4
Xi-fold for each flux: mouse flux/human flux.
1Per kg of body weight.
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Metabolic fluxes
The metabolic fluxes (MFs) of glucose to glucose-6-
phosphate (/GLC?G6P) and glycogen to glucose-6-phos-
phate (/GLY?G6P) are available in literature for mouse
liver, which are determined using isotope tracers
(Table 1). For any MF that is not known from litera-
ture, we assume organ/tissue MFs that the reaction flux
(per unit weight of organ/tissue) in mouse is equal to
the reaction flux in human (Table 1). This assumption
corresponds to the flux relationship between /GLC?G6P
and /GLY?G6P from MFs measured in mouse and
human liver (Mulligan and Tisdale 1991; Kim et al.
2007; Chacko et al. 2012).
Table 8. Mouse organ/tissue metabolic fluxes.
Fluxes
Metabolic fluxes (lmol/min/kg)1
Brain Heart Liver GI Skeletal muscle Adipose tissue
GLC ? G6P 764.4 108.7 73.1 54.5 58.3 59.3
G6P ? GAP 764.4 108.7 73.1 54.5 58.3 59.3
GAP ? PYR 1528.8 217.5 146.2 109.0 116.6 72.5
PYR ? GAP – – 1443.6 – – –
GAP ? G6P – – 1978.5 – – –
G6P ? GLC – – 1228 – – –
G6P ? GLY 2.0 160.0 66.7 – 6.25 –
GLY ? G6P 2.0 160.0 305.4 – 6.25 –
PYR ? LAC 469.8 352.0 140.0 100.0 77.2 3.3
LAC ? PYR 469.8 1060.3 577.1 100.0 44.4 0.9
GLR ? GRP – 16.0 548.4 – 6.3 0.0
GAP ? GRP – – 0.0 – 0.0 46.1
GRP ? GAP – – 534.9 – 0.0 –
PYR ? ALA – – 0.0 – 26.5 –
ALA ? PYR – – 860.2 – 0.00 –
PYR ? ACoA 1528.8 925.8 0.0 109.0 57.3 70.2
FFA ? ACoA – 268.8 569.7 – 14.2 22.3
ACoA ? FFA – – 74.7 – – –
TGL ? GLR – 16.0 2.7 117.8 6.50 230.6
FFA ? TG – 48.0 40.4 – 18.9 138.4
ACoA ? CO2 1528.8 3076.1 4483.1 109.0 170.7 248.6
O2 ? H2O 4586.3 8959.4 12418.8 327.1 511.3 700.5
ATP ? ADP 30574.1 56241.7 72908.6 2180.5 3276.6 4156.8
Protein ? ALA – – – – 129.3 –
Values in bold are assumed fluxes (see Table 1) and the rest are calculated with flux balance analysis.
1Per kg of organ weight.
Table 9. Carbohydrates and fat oxidation rates in mouse and human organs.
Organ/Tissue
Substrate utilization (lmol/min/kg)1 Xi-fold
Mouse Human Mouse/Human
CHO FAT CHO FAT CHO FAT
Brain 30574 0 10199 0 3.0 –
Heart 17163 39079 9028 20300 1.9 1.9
Liver 4251.2 77160 1700 11078 2.5 7
GI tract 2180.5 0 1520 0 1.4 –
Skeletal muscle 1197.7 2078.9 180.84 360.21 6.6 5.8
Adipose tissue 1282.7 2874.2 52.12 117.52 24.6 24.5
CHO, carbohydrate; FAT, fat.
Xi-fold for each organ/tissue: mouse substrate utilization/human substrate utilization.
Negative sign indicates CHO production.
1Per kg of organ weight
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Organ energy expenditure
To calculate EE of mouse organs and tissues, we used an
allometric function that relates EE (kcal/kg/day) to body
mass BW (kg) (Wang et al. 2012):
EEx ¼ axBWbx (9)
where ax and bx are the parameters for organ x, which
are reported in Table 11. EEx refers to the energy expen-
diture of organs and tissues, and BW refers to the mouse
whole body mass under overnight fasting conditions
(unless otherwise specified). Similar allometric functions
that relate organ size to body mass were successfully used
to estimate organ masses of different mature mammalian
species ranging in body size from mice to elephants (Elia
1992; Wang et al. 2001). Furthermore, the whole-body EE
determined from the sum of the EE of individual organs
predicted the whole-body EE, which is a function of BW
(Wang et al. 2012). Therefore, we chose this relation as a
first approximation to obtain mouse organ/tissue EE.
This allometric equation was used to calculate EE only
for brain, heart, liver, kidney, and “residual” organs/tis-
sues. The EE of the GI tract was evaluated using equa-
tion (9) with the parameters of the “residual organs”. The
EE of “others” was evaluated as the weighted average of
kidney EE and other nonspecified organs and tissues. Kid-
ney EE was evaluated using equation (9). Other nonspeci-
fied organs and tissues EE was determined using
BLOOD
TISSUE
GLC G6P GLY
GAP GRP
GLR
TG
LAC
PYR
ALA
ACoA
FFA
CO2 H2OO2
ATPADP
NADH NAD+
Protein
*
*
*
*
*
*
* *
Figure 2. General metabolic pathways in whole-body model. Eight
substrates connected with open arrays are transported between
tissue and blood. While gray arrows are common pathways in all
tissues, black arrows are tissue-specific pathways. The pathways
marked with (*) are composed of several reaction steps but lumped
into one step in this model. ADP, adenosine diphosphate; ATP,
adenosine triphosphate; ACoA, acetyl CoA; AA, amino acids; GLC,
glucose; G6P, glucose-6-phosphate; GAP, glyceraldehyde-3-
phosphate; GLR, glycerol; GRP, glycerol-3-phosphate; GLY,
glycogen; FFA, free fatty acid; LAC, lactate; PYR, pyruvate; TG,
triglycerides.
Figure 3. Map for tissue-specific metabolic pathways. In addition to the common pathways shown in Figure 2, each tissue has different kinds
of metabolic pathways. Blank filled with gray color means the existence of the corresponding pathway.
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equation (9) with the parameters of the “residual organs”.
The adipose tissue EE was evaluated using the specific
metabolic activity of fat mass proposed in a previous
study (Guo and Hall 2011) (Appendix 4). Muscle EE was
evaluated subtracting EEs of brain, heart, liver, GI, and
“others” from the fat-free mass (FFM) EE of the whole
body. The EE of mouse and human FM and FFM are
reported in Appendix 4. For human tissues/organs, the
values of EE was evaluated using sum of the carbohydrate
and fat substrate utilization rates estimated from flux bal-
ance analysis (Kim et al. 2007). The EE of mouse and
human organs and tissues are reported in Table 4.
Mouse whole-body VO2 prediction
Using body composition and oxygen consumption data
for each organ and tissue, the whole-body VO2 (mL/h)
can be predicted according to:
VO2 ¼
X
x
Mx VO2;x (10)
where Mx is the organ/tissue mass (g) and VO2,x is the
oxygen consumption (mL/h/g) of the organ/tissue x of a
30 g wild-type mouse. For this prediction, the masses
(Fig. 4A) and estimated rates of VO2 (Table 6) of mouse
organs/tissues were used for HRS/J strain of mice at 23
and 30°C (Konarzewski and Diamond 1995).
Sensitivity analysis
We simulated the effect of 25% changes of the meta-
bolic fluxes and substrate uptake/release rates from mouse
basal levels (Tables 1 and 2) derived from human data on
carbohydrate and fat utilization rates. Some simulations
of metabolic flux or substrate uptake/release variations
produced negative intraorgan fluxes that were ignored as
not physiological.
Results
Energy expenditure
The EE (per organ/tissue mass) of all mouse organs/tis-
sues is significantly higher than their respective human
organs/tissues (Table 4). The EE of brain, heart, liver, and
GI tract in mouse is 3.0, 1.9, 7.8, and 1.4 times higher
than the respective organ/tissue in human. The EE of
muscle and adipose tissue in mouse are 6.0 and 24.5
times higher than those tissues in human. The EE of FFM
and FM in mouse are 7.9 and 25.0 times higher than
those tissues in human (Appendix 4).
Organ/tissue metabolic fluxes and rates
For each organ/tissue, Equations (2–6) were solved to
quantify metabolic fluxes and rates of O2 consumption,
CO2 production, as well as rates of substrate uptake/
release and utilization. As a representative case, the model
Table 10. Appearance rates of metabolic fuels in the plasma of mouse and human.
Metabolic fuel
Appearance rate (Ra) (lmol/min/kg)
1 Appearance rate (Ra) (lmol/min)
Xi-fold
Mouse Human Mouse Human Mouse/Human
Glucose 71.6  4.57 (Chacko et al. 2012) 10.87 2.150.14 761.0 6.59
Lactate 31.12 (this work) 4.43 0.93 (this work) 310.0 7.02
Pyruvate 0.0 (this work) 0.07 0.0 (this work) 5.0 NA
Alanine 64.9  11.8 (Andrikopoulos and
Proietto 1995)
4.57 1.95  0.35 320.0 14.21
Free Fatty acid 96.3  17.3 (Bergman et al. 2006) 4.73 2.89  0.52 331.0 20.37
Glycerol 32.6  4.3 (Xu et al. 2002) 2.00 0.98  0.13 140.0 16.30
Triglyceride 0.67  0.03 (Goudriaan et al. 2005) 0.41 0.020  0.001 29.0 1.63
NA, not available.
Xi-fold for each organ/tissue: mouse Ra (lmol/kg/min)/human Ra (lmol/kg/min).
1Per kg of body weight.
The references for mouse substrate appearance rates are reported in the brackets. Human substrate appearance rates were obtained from
Kim et al. (2007).
Table 11. Parameters of the organ/tissues EE allometric relation-
ships (Wang et al. 2012).
Organ/Tissue a b
Brain 446.6 0.1423
Heart 890.3 0.1181
Liver 683.9 0.2677
Kidneys 689.7 0.0833
Other organs 29.96 0.1667
2014 | Vol. 2 | Iss. 9 | e12159
Page 10
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Comparison of Mouse and Human Energy Metabolism C. M. Kummitha et al.
calculation to estimate the liver metabolic fluxes is given
in the Appendix 6 and results are presented in Figure A1.
The inputs to the model equations are reported in the
Tables 1–4 and 10. The solution of the mass and energy
balance provides the rates of substrate uptake/release and
gas exchange of mouse organs/tissues (Tables 5, 6)
and whole body (Table 7), the metabolic fluxes (Table 8),
and substrate utilization (Table 9). For convenience, the
simulated metabolic pathway fluxes are reported in
Table 8 with the input metabolic fluxes highlighted in
bold.
Glucose uptake and gas exchange rates
The estimated glucose uptake in the brain and adipose
tissue is within the range of the measured glucose uptake.
The estimated glucose uptake, for heart is almost twofold
higher, and for GI tract is an order-of-magnitude lower,
than the measured glucose uptake (See Table 5). The VO2
and VCO2 are compared with those calculated with the
standard approach Eq. (9) (Tang et al. 2002) (Table 6).
The VO2 and VCO2 for brain, heart, GI tract, muscle,
and adipose tissue estimated using these two approaches
are similar. In contrast, the VO2 and VCO2 of the liver
differ significantly between these two approaches.
Whole-body metabolic fluxes
With our methods, we could estimate whole-body meta-
bolic fluxes including glycogenolysis and gluconeogenesis
(Table 7). The equations that relate organ/tissue to
whole-body metabolic fluxes are provided in Appendix 5.
The results quantify the higher whole-body metabolic
fluxes in mouse compared to human. Gluconeogenesis in
mouse is about 11 times higher than that in human. The
rates of de novo lipogenesis, proteolysis, and lipolysis are
about 16, 11, and 9 times respectively higher in mouse
than those in human.
Substrate utilization rates
The rates of carbohydrate (CHO) and FAT utilization in
mouse organs/tissues are higher compared to human
(Table 9). FAT utilization is absent in the brain and GI
tract of mouse and human. The relative contributions of
CHO and FAT to energy production are reported in
Table 12. The percent contribution of CHO and FAT to
energy production in the liver is significantly different for
mouse and human, but they are only slightly different in
heart, muscle, and adipose tissue. CHO is the only fuel
for brain and GI tract energy metabolism and FAT utili-
zation is absent in these organs. The negative carbohy-
drate utilization of liver indicates that liver is producing
glucose with the energy from fat metabolism.
Whole-body VO2 prediction
The predicted organ and whole-body VO2 at 23°C
and 30°C for HRS/J strain of mice were reported in
A B
Figure 4. (A) Body composition; (B) Comparison of whole-body VO2 of the HRS/J mouse strain between simulated and experimental data
obtained at 23 and 30°C.
Table 12. Contribution of CHO and FAT oxidation to substrate
utilization in mouse and human organs.
Organ/Tissue
CHO (%) FAT (%)
Mouse Human Mouse Human
Brain 100.0 100.0 0.0 0.0
Heart 30.5 30.8 69.5 69.2
Liver 5.8 18.1 105.8 118.1
GI tract 100.0 100.0 0.0 0.0
Skeletal muscle 36.6 33.4 63.4 66.6
Adipose tissue 30.9 30.7 69.1 69.3
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Figure 4B. The simulated whole-body VO2 is close to
the experimental value at 23°C, while the simulated VO2
at 30°C is slightly higher than the measured value
(Konarzewski and Diamond 1995).
Sensitivity analysis
The sensitivity results are presented in Figure 5. When
/G6P?GLY flux in liver varied by 25%, the carbohydrate
utilization value varied slightly (2.7%) and the fat utili-
zation varied less than 1% (Fig. 5A). From a 25% var-
iation of UptGLR,Liver, the carbohydrate utilization
changed by 9.6%, and the fat utilization varied less than
1% (Fig. 5B). When RelLAC,SM varied by 25%, small
changes occurred in carbohydrate (4.1%) and fat utili-
zation (2.4%) (Fig. 5C). The variation in other meta-
bolic fluxes and substrate uptake/release (25%) derived
from human data (Tables 1 and 2) had negligible (<1%)
effect on carbohydrate and fat utilization rates. When
/FFA?TG flux and RelFFA and RelGLR rates in adipose tis-
sue were changed by 25%, the results produced negative
values of metabolic fluxes, which are not physiological.
The simultaneous (+25%) variation of RelFFA and RelGLR
affected carbohydrate and fat utilization rates by +20%
and 40%, respectively (Fig. 5D).
Discussion
Mouse metabolism
In this study, a multiorgan analysis is applied to obtain
mouse organ/tissue metabolic fluxes and rates of exchange
of substrates. Using mass and energy balances for each
organ, the rates of organ/tissue carbohydrate and fat utili-
zation are evaluated. In turn, rates of substrate utilization
were used to obtain organ/tissue energy expenditure (EE).
The whole-body and organ/tissue physiological parameters,
EE, rates of substrate utilization, and rates of oxygen con-
sumption of mice and humans are compared to quantify
the differences in their energy and metabolic processes.
Flux balance analysis in determining energy
expenditure
The flux balance analysis with limited experimental data
(organ/tissue metabolic fluxes and whole-body metabolic
A B
C D
Figure 5. Sensitivity analysis. The effect of variation (25% from the base case value) of /G6P?GLY in liver (A), UptGLR in liver (B), RelLAC, in
skeletal muscle (C), and simultaneous variation (25% from the base case value) of RelFFA and RelGLR in adipose tissue (D) on carbohydrate and
fat utilization.
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parameters) can be used to quantify the fluxes that can-
not be obtained easily with experiments and identifies the
number of experiments required for obtaining unknown
measurements (Tables 5, 7, 8). Currently, experimental
data related to rates of free fatty acid uptake of heart,
liver, skeletal muscle, lactate uptake/release of liver and
adipose tissue, and glycerol release from GI tract are not
available for mice. Our model analysis yields estimates of
these rates. Furthermore, the model also estimates rates of
glucose uptake for brain, heart, adipose tissue, and GI
tract. We observed few differences between rates of glu-
cose uptake obtained with model simulations and experi-
ments. The rates of glucose uptake of brain and adipose
tissue derived with model simulations are consistent with
the experimental data (Table 5). This indicates that the
model proposed with EE values and other assumptions
utilized for these organs are consistent with experimental
data obtained under similar physiological conditions. On
the other hand, significant differences were noticed
between estimated and measured rates of glucose uptake
for heart and GI tract (Table 5). These differences in glu-
cose uptake could be related to the inputs values for EE
used for heart and GI tract. It is expected that for the
same RQ, the increase in the EE of organs/tissues results
in the simultaneous increase in the rates of carbohydrate
and fat oxidation, which is followed by an increase in glu-
cose and fatty acid uptake and vice versa. Therefore, the
lower (or higher) glucose uptake for GI tract (or heart)
can be caused by an underestimation (or overestimation)
of the EE determined by allometric functions. This was
verified by simulations using different EE values of GI
tract and heart. The actual EE of GI tract and heart used
for the FBA are 0.14 and 0.23 kcal/day, respectively. It
was found that at 0.61 kcal/day EE value, the GI tract
measured, and estimated rates of glucose uptake
(234.3 lmol/min/kg) are the same. At 0.2 kcal/day EE
value, the measured and calculated rates of glucose uptake
by the heart (49.1 lmol/min/kg) are the same and the
free fatty acid uptake by the heart decreased from 268.8
to 234.3 lmol/min/kg (Table 5).
Sensitivity analysis for model justification
and experiment design
Under the assumption that the metabolic flux per unit
organ/tissue mass in mouse and human are similar
(Table 1), sensitivity analysis indicates that variations of
most metabolic fluxes have a minor effect on the organ
substrate utilization. Under the assumption that the
appearance rate fractions of metabolic fuels in organs/tis-
sues are similar in both human and mouse (Table 2),
variations in all organ/tissue substrate uptake/release rates,
only a few showed moderate sensitivity to carbohydrate
and fat utilization. (Fig. 5B and C). Since FFA and GLR
are both stoichiometrically related to lipolysis (3:1),
RelFFA and RelGLR rates (Table 2) are closely coupled and
significantly affect carbohydrate and fat utilization rates.
Therefore, the relationship between RelFFA and RelGLR in
mouse is similar in human. Since RelFFA and RelGLR were
estimated using appearance rates of Ra,FFA and Ra,GLR
from mouse, the substrate utilization rates estimated in
the base case (Table 9 and 12) are plausible. Variation of
most assumptions in Tables 1 and 2 has minimal effects
on estimates of organ and whole-body substrate utiliza-
tion. This sensitivity analysis not only quantified the effect
of assumptions on the model outputs, but also identified
the most critical metabolic fluxes affecting organ substrate
utilization and energy expenditure.
Whole-body metabolic fluxes
The model also yields estimates of whole-body metabolic
fluxes including gluconeogenesis, de novo lipogenesis,
glycogenolysis, lipolysis, proteolysis, and oxidation of ma-
cronutrients (Tables 7, 9, and 12). These fluxes are higher
in mouse than those in human organs/tissues. For exam-
ple, the rates of gluconeogenesis and glycogenolysis in
mouse liver are 11.4 and 2.7 fold higher than that in
human liver, respectively. This is mainly due to the differ-
ence in the utilization of glucose as the fuel under over-
night fasting conditions. This is supported by a glucose
level in mouse plasma 6.6-fold higher than that in
human. The major source of glucose production under
fasting conditions via gluconeogenesis and glycogenolysis
is the liver.
Comparison of mouse and human
metabolism
The whole-body energy expenditure (expressed per unit
BW) in mouse is significantly higher than in human. Fur-
thermore, the organ/tissue contribution to the whole-
body metabolic rate differs in mouse and human. The
liver consumes about 52% and 20% of whole-body energy
expenditure in mouse and human, respectively, whereas
the contributions of brain, heart, GI tract, skeletal muscle
to the whole-body energy expenditure in mouse are com-
paratively smaller than those in human (Table 4). These
differences in the energy expenditure of mice and humans
can be related to differences in the body composition and
organ/tissue metabolic activities. While the size of liver
and GI tract in mouse relative to body weight are about 3
times that in human, the proportions of skeletal muscle
and adipose are lower in mice than that in human
(Table 3). The energy expenditure of organs and tissues
are higher in mouse than in human (Table 4), which can
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 9 | e12159
Page 13
C. M. Kummitha et al. Comparison of Mouse and Human Energy Metabolism
be related to the differences in the cellular and structural
constituents of organs and tissues in these species.
Although no direct evidence supports this argument, it
can be inferred from studies (Elia 1992) that the energy
expenditure of rat cerebral tissue is twofold higher than
that in human. The higher energy expenditure of rat cere-
bral tissue was linked to a much smaller proportion of
glial cells (i.e., lower energy expenditure). Furthermore,
fiber type and composition of skeletal muscle vary across
species. Similar muscles in different species may have dif-
ferent functional and metabolic properties (Schiaffino and
Reggiani 2011; Bloemberg and Quadrilatero 2012). The
citrate synthase activity, an indicator of mitochondria
content, is higher in mouse than in human skeletal mus-
cle, while the fraction of type I fibers in human skeletal
muscle is higher than in rodents (Schiaffino and Reggiani
2011). Thus, the higher energy expenditure in mouse can
be attributed to the higher mitochondrial density. The
higher energy expenditure of mouse at whole-body and
organ/tissue levels is also related to higher rates of organ/
tissue carbohydrate and fat oxidation (Table 9) and
higher rates of glycogenolysis, gluconeogenesis, de novo
lipogenesis, proteolysis, and lipolysis whole-body meta-
bolic fluxes (Table 7). The higher metabolic activity is
also related to more heat loss in mouse than in human
(Blaxter 1989).
Mouse oxygen consumption rate
The model predicted the whole-body VO2 at 23°C for
HRS/J strain (Fig. 4B), but overestimated VO2 at 30°C by
15%. This may be related to data at ambient temperature,
which can have a significant effect on the mouse meta-
bolic rate (Speakman 2013). A temperature variation of
7–10°C leads to 10–30% of change of the basal metabolic
rate (Konarzewski and Diamond 1995; Golozoubova et al.
2004) Therefore, an overestimation of the basal metabolic
rate of 15% appears plausible since the model does not
take into account the effect of the temperature on the
energy expenditure.
The liver VO2 from flux balance analysis differ from
indirect calorimetry (Table 6). This difference is mainly
due to the inclusion of the stoichiometric reactions of
glycogenolysis, gluconeogenesis from alanine and glycerol
used for quantifying EE from the main metabolic path-
ways.
Overview of model analysis
In this study, the organ/tissue contributions to the energy
expenditure are quantified using a system of mass and
energy balance equations based on the fluxes of the main
energy metabolism pathways of each organ. This analysis
incorporates available data on metabolic fluxes, substrate
uptake and release rates, respiratory quotient (Tables 1–
3), and organ/tissue EE allometric relationships. Since
experimental data in support of various assumptions are
lacking, the reliability of the model predictions is limited.
On the other hand, this model analysis can be applied to
identify the minimal set of metabolic flux measurements
to determine the organ/tissues EE without using any
assumptions for EE, metabolic fluxes, or respiratory quo-
tients in Tables 1–3.
Conclusions
The methodology developed in this study can be useful in
the design of experimental studies to quantify the meta-
bolic fluxes affecting energy expenditure in mouse models
of disease. Furthermore, an integrative approach that
combines limited experimental data and computational
modeling can quantify changes in the tissue/organ meta-
bolic activities taking into account body composition and
metabolic or physiological differences between species. In
future studies, contributions of kidney, lungs, and skin to
the whole-body energy balance can be included when suf-
ficient data becomes available. To analyze weight regula-
tion in disease, diet, or exercise, the tissue/organ
metabolic flux network presented here would have to be
integrated with hormonal control. In summary, the
method presented quantifies the energy expenditure of
mouse organs using metabolic flux measurements. This
methodology can be used as an alternative approach to
the traditional measurements based on Fick’s principle to
determine the organ energy expenditure. The theoretical
framework is a paradigm for direct and quantitative
human–mouse comparison of fuel utilization in tissue/
organ systems and whole-body fluxes under various meta-
bolic or physiological conditions.
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Appendix 1
Biochemical reactions of the metabolic pathways in tissue/organ x
1. Glycolysis I GLC + ATP ? G6P + ADP
2. Glycolysis II G6P + ATP ? 2GAP + ADP
3. Glycolysis III GAP + Pi + NAD+ + 2ADP ? PYR + NADH + 2ATP
4. Gluconeogenesis I PYR + 3ATP + NADH ? GAP + 3ADP + NAD+ + 2Pi
5. Gluconeogenesis II 2GAP ? G6P + Pi
6. Gluconeogenesis III G6P ? GLC + Pi
7. Glycogenesis G6P + ATP ? GLY + ADP + 2Pi
8. Glycogenolysis GLY + Pi ? G6P
9. Pyruvate reduction PYR + NADH ? LAC + NAD+
10. Lactate oxidation LAC + NAD+ ? PYR + NADH
11. Glycerol phosphorylation GLR + ATP ? GRP + ADP
12. GAP reduction GAP + NADH ? GRP + NAD+
13. Glycerol 3-P oxidation GRP + NAD+ ? GAP + NADH
14. Alanine formation PYR ? ALA
15. Alanine utilization ALA ? PYR
16. Pyruvate oxidation PYR + CoA + NAD+ ? ACoA + NADH + CO2
17. Fatty acid oxidation FA + 8CoA + 2ATP + 14NAD+ ? 8ACoA + 2ADP + 2Pi + 14NADH
18. Fatty acid synthesis 8ACoA + 7ATP + 14NADH ? FA + 8CoA + 7ADP + 7Pi + 14NAD+
19. Lipolysis TGL ? GLR + 3FA
20. Triglyceride synthesis GRP + 3FA + 6ATP ? TGL + 6ADP + 7Pi
21. TCA cycle ACoA + ADP + Pi + 4NAD+ ? 2CO2 + CoA + ATP + 4NADH
22. Oxidative phosphorylation O2 + 6ADP + 6Pi + 2NADH ? 2H2O + 6ATP + 2NAD
+
23. Protein breakdown Protein ? ALA
24. ATP hydrolysis ATP ? ADP + Pi
Figure A1. The model equations were solved using the function fsolve in MATLAB. Some of the data inputs were highlighted in bold font in
the flux balance diagram. The other data inputs are, RQ: 0.72; EE: 225.7 105 kcal min1; CECHO: 16.8 109 kcal nmol1; CEFAT: 16.6
109 kcal nmol1; All metabolic fluxes are in nmol min1.
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Appendix 2
Steady-state mass balance equations of metabolite in tissue/organ x
1. Glucose /G6P?GLC  /GLC?G6P + Qx(Ca,GLC  Cv,GLC) = 0
2. Pyruvate /GAP?PYR + /LAC?PYR + /ALA?PYR  /PYR?GAP  /PYR?LAC  /PYR?ALA  /PYR?ACoA + Qx(Ca,PYR  Cv,PYR) = 0
3. Lactate /PYR?LAC  /LAC?PYR + Qx(Ca,LAC  Cv,LAC) = 0
4. Alanine /PYR?ALA + /Protein?ALA  /ALA?PYR + Qx(Ca,ALA  Cv,ALA) = 0
5. Glycerol /TG?GLR  /GLR?GRP + Qx(Ca,GLR  Cv,GLR) = 0
6. Free Fatty acid 3/TG!GLR þ 18/ACOA!FFA  /FFA!TG  /FFA!ACOA þ QxðCa;FFA  Cv;FFAÞ ¼ 0
7. Triglyceride 13/FFA!TG  /TG!GLR þ QxðCa;TG  Cv;TGÞ ¼ 0
8. Oxygen  /O2!H20
 þ QðCA;O2  CV;O2 Þ ¼ 0
9. Carbon dioxide /PYR!ACOA þ 2 /ACOA!CO2
 þ QxðCa;CO2  Cv;CO2 Þ ¼ 0
10. Glucose 6 phosphate /GLC!G6P þ 12 /GAP!G6P½  þ /GLY!GAP  /G6P!GAP  /G6P!GLC  /G6P!GLY ¼ 0
11. Glycogen /G6P?GLY  /GLY?G6P = 0
12. Glyceraldehyde Phosphate 2 /G6P!GAP½  þ /PYR!GAP þ /GRP!GAP  /GAP!PYR  /GAP!G6P  /GAP!GRP ¼ 0
13. Glycerol phosphate /GLR!GRP þ /GAP!GRP  /GRP!GAP  13/FFA!TG ¼ 0
14. Acetyl coenzyme A /PYR!ACOA þ 8/FFA!ACOA  /ACOA!FFA  /ACOA!CO2 ¼ 0
15. Coenzyme A /ACOA!CO2 þ /ACOA!FFA  /PYR!ACOA  8/FFA!ACOA ¼ 0
16. NAD+
/PYR!GAP þ /PYR!LAC þ /GAP!GRP þ
14
8
/ACOA!FFA þ 2/O2!H2O
 /GAP!PYR  /LAC!PYR  /GRP!GAP  /PYR!ACOA  14/FFA!ACOA  4/ACOA!CO2 ¼ 0
17. NADH /GAP!PYR þ /LAC!PYR þ /GRP!GAP þ /PYR!ACOA þ 14/FFA!ACOA þ 4/ACOA!CO2
 /PYR!GAP  /PYR!LAC  /GAP!GRP 
14
8
/ACOA!FFA  2/O2!H2O ¼ 0
18. ATP 2/GAP!PYR þ /ACOA!CO2 þ 6/O2!H2O þ /PCR!CR  /GLC!G6P  /G6P!GAP  3/PYR!GAP
 /G6P!GLY  /GLR!GRP  2/FFA!ACOA 
7
8
/ACOA!FFA  2/FFA!TG  /CR!PCR  /ATP!ADP ¼ 0
19. ADP /GLC!G6P þ /G6P!GAP þ 3/PYR!GAP þ /G6P!GLY þ /GLR!GRP þ 2/FFA!ACOA þ
7
8
/ACOA!FFA
þ 2/FFA!TG þ /CR!PCR þ /ATP!ADP  2/GAP!PYR  /ACOA!CO2  6/O2!H2O  /PCR!CR ¼ 0
20. Pi 2/PYR!GAP þ
1
2
/GAP!G6P þ /GAP!GLC þ 2/G6P!GLY þ 2/FFA!ACOA þ
7
8
/ACOA!FFA
þ 7
3
/FFA!TG þ /ATP!ADP  /GAP!PYR  /GLY!G6P  6/O2!H2O  /ACOA!CO2 ¼ 0
Appendix 3
Energy balance equations
Organ/Tissue Carbohydrate utilization, /CHOATP!ADP
Brain 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP  /G6P!GLY
Heart 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP  /G6P!GLY
Liver 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP  3/PYR!GAP  /G6P!GLY
GI tract 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP
Skeletal muscle 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP  /G6P!GLY
Adipose tissue 2/GAP!PYR þ xCHO /ACOA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP
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Fat utilization /FATATP!ADP
Brain xFAT /ACOA!CO2 þ 6/O2!H2O
 
Heart xFAT /ACOA!CO2 þ 6/O2!H2O
  /GLR!GRP  2/FFA!ACOA  2/FFA!TG ¼ 0
Liver xFAT /ACOA!CO2 þ 6/O2!H2O
  /GLR!GRP  2/FFA!ACOA  7=8/ACOA!FFA  2/FFA!TG
GI tract xFAT /ACOA!CO2 þ 6/O2!H2O
 
Skeletal muscle xFAT /ACOA!CO2 þ 6/O2!H2O
  /GLR!GRP  2/FFA!ACOA  2/FFA!TG
Adipose tissue xFAT /ACOA!CO2 þ 6/O2!H2O
  2/FFA!ACOA  2/FFA!TG
Where carbohydrate and fat oxidation fraction is defined as follows:
/PYR!ACoA
/ACoA!CO2
 xCHO ¼ 0; /FA$ACoA/ACoA!CO2
 xFAT ¼ 0; xCHO þ xFAT ¼ 1
The overall energy balance for each organ/tissue system is
/CHOATP!ADPCE
CHO þ /FATATP!ADPCEFAT  EE ¼ 0
where, CECHO (16.825 109 kcal/nmol) and CEFAT 16.653 109 kcal/nmol) are the carbohydrate and fat calorific equiva-
lent of ATP, respectively.
Appendix 4
Estimation of FM and FFM energy expenditure
Under fasting conditions, the energy expenditure (EE) model for mouse reported by Guo and Hall (2011) reduces to
EE ¼ Kþ cFMFMþ cFFMFFM
Where K is the basal thermogenesis rate, while cFM (30 kcal/kg/day) and cFFM (150 kcal/kg/day) are the specific
metabolic rates of fat mass (FM) and free fat mass (FFM), respectively. The EE of FM and FFM are calculated with the
following equations:
EEFM ¼ ðk þ cFMÞFM
EEFFM ¼ ðk þ cFFMÞFFM
where k (per unit of body mass) is added to the metabolic rates of FFM and FM. We assumed that each gram of 30 g
mouse equally contributes to basal thermogenesis. Therefore, k (K per unit of body mass) is 70 kcal/kg/day. The energy
expenditure of FFM and FM are reported in Table 4.1.
Table 4.1. Energy Expenditure of fat and fat-free mass of mouse and human.
EE (kcal/kg/day)1
Xi-fold
Mouse (Guo and Hall 2011) Human (Kim et al. 2007) Mouse/Human
Fat-free mass (FFM) 220.0 28.0 7.8
Fat mass (FM) 100.0 4.0 25.0
1Per kg of FFM and per kg of FM.
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Human FFM EE (per unit FFM mass) was obtained by dividing sum of the absolute EEs of brain, heart, liver, GI
tract, muscle, and others with their total mass and FM EE (per unit FM mass) is similar to the adipose tissue EE (per
unit adipose mass).
Appendix 5
Whole-body metabolic fluxes
1. Glycogenolysis =
P
i
/GLY!G6P  /G6P!GLY½  where i is brain, heart, liver, GI, muscle, and adipose
2. Gluconeogenesis = /GAP!G6P2  /G6P!GAP
h i
Liver
3. De novo lipogenesis
P
i
/GAP!GRP½  where i is brain, heart, liver, GI, muscle, and adipose
4. Proteolysis =
P
i
/Protein!ALA½  where i is brain, heart, liver, GI, muscle, and adipose
5. Lipolysis =
P
i
/TG!GLR½  where i is brain, heart, liver, GI, muscle, and adipose
Appendix 6
Model calculations for quantifying liver metabolic fluxes
No of equations: (21)
Mass balance (19), energy balance (1), congruence relationship (1)
No of variables: (38)
RQ, EE, CECHO, CEFAT, RelGLC, RelTG, UptGLR, UptALA, UptLAC, UptFFA, UptO2 , RelCO2 ,
/GLC!G6P;/G6P!GAP;/GAP!PYR;/PYR!LAC;/G6P!GLY;/GLY!G6P;/TG!GLR;/ACoA!FFA;
/PYR!ACoA;/G6P!GLC;/GAP!G6P;/PYR!GAP;/GRP!GAP;/LAC!PYR;/ALA!PYR;/FFA!TG;
/GLR!GRP;/TG!FFA;/GRP!TG;/FFA!ACoA;/ACoA!CO2 ;/O2!H20;/ATP!ADP; xCHO;
/CHOATP!ADP;/
FAT
ATP!ADP:
Number of data inputs: (3821 = 17)
RQ, EE, CECHO, CEFAT, RelGLC, RelTG, UptGLR, UptALA,
/GLC!G6P;/G6P!GAP;/GAP!PYR;/PYR!LAC;/G6P!GLY;/GLY!G6P;/TG!GLR;/ACoA!FFA;/PYR!ACoA:
Substrate steady-state mass and energy balance equations (21)
1. Glucose /G6P!GLC  /GLC!G6P  RelGLC ¼ 0
2. Glucose-6-phosphate /GLC!G6P þ 12 /GAP!G6P½  þ /GLY!G6P  /G6P!GAP  /G6P!GLC  /G6P!GLY ¼ 0
3. Glyceraldehyde phosphate 2 /G6P!GAP½  þ /PYR!GAP þ /GRP!GAP  /GAP!PYR  /GAP!G6P ¼ 0
4. Lactate /PYR?LAC  /LAC?PYR + UptLAC = 0
5. Pyruvate /GAP?PYR + /LAC?PYR + /ALA?PYR  /PYR?GAP  /PYR?LAC  /PYR?ACoA = 0
6. Alanine  /ALA?PYR + UptALA = 0
7. Triglyceride 13/FFA!TG  /TG!GLR  RelTG ¼ 0
8. Glycerol /TG?GLR  /GLR?GRP + UptGLR = 0
9. Glycerol phosphate /GLR!GRP  /GRP!GAP  13/FFA!TG ¼ 0
10. TG to FFA /TG?FFA  3/TG?GLR = 0
11. GRP to TG /GRP!TG  13
 
/FFA!TG ¼ 0
12. Free fatty acid 3/TG!GLR þ 18/ACoA!FFA  /FFA!TG  /FFA!ACoA þ UptFFA ¼ 0
13. Acetyl coenzyme A /PYR!ACoA þ 8/FFA!ACoA  /ACoA!FFA  /ACoA!CO2 ¼ 0
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14. Oxygen  /O2!H20
 þ UptO2 ¼ 0
15. Carbon dioxide /PYR!ACoA þ 2 /ACoA!CO2
  RelCO2 ¼ 0
16. Respiratory quotient RelCO2  RQ UptO2 ¼ 0
17. ATP 2/GAP!PYR þ /ACoA!CO2 þ 6/O2!H2O  /GLC!G6P  /G6P!GAP  3/PYR!GAP
 /G6P!GLY  /GLR!GRP  2/FFA!ACoA 
7
8
/ACoA!FFA  2/FFA!TG  /ATP!ADP ¼ 0
18. CHO utilization 2/GAP!PYR þ xCHO /ACoA!CO2 þ 6/O2!H2O
  /GLC!G6P  /G6P!GAP  3/PYR!GAP
 /G6P!GLY  /CHOATP!ADP ¼ 0
19. FAT utilization 1 xCHOð Þ /ACoA!CO2 þ 6/O2!H2O
  /GLR!GRP  2/FFA!ACoA  7=8/ACoA!FFA
 2/FFA!TG  /FATATP!ADP ¼ 0
20. CHO contribution to TCA cycle /PYR!ACoA  xCHO/ACoA!CO2 ¼ 0
21. Overall energy balance CECHO/CHOATP!ADP þ CEFAT/FATATP!ADP  EE ¼ 0
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